What Telemedicine Actually Replaces

A medication check-in, a follow-up after a procedure that is healing normally, a mental-health session, a renewed prescription for a condition already diagnosed — all of these are conversations, and a conversation works over video exactly as well as it works in a room. For a patient who would otherwise take half a day off work and drive an hour each way, replacing that visit with a fifteen-minute call is not a compromise. It is strictly better.

The savings compound in a specific direction too — toward the patient who has the least slack to spare. A parent who can take a fifteen-minute call from a break room keeps their income for the day; a parent who has to arrange transport, childcare, and half a day of unpaid leave for a five-minute conversation with a doctor is paying a cost that has nothing to do with medicine at all.

A doctor cannot listen to your lungs, feel a suspicious lump, or set a broken bone through a screen. Anything that depends on physical contact, a specific piece of equipment in the room, or an intervention happening right now cannot move to video — not because the technology isn't good enough yet, but because the thing being replaced was never just a conversation.

There is a third category the replace-or-can't framing misses, and it complicates the tidy story that telemedicine straightforwardly saves the system money: visits that would not have happened in any form without the cheap, easy option, which means they are not replacing an in-person visit at all — they are new demand.

One frequently cited study of a large direct-to-consumer telehealth service found that only about 12% of its visits substituted for a visit that would otherwise have happened in person or at an emergency room. The remaining share was largely new utilisation — visits for symptoms a patient would most likely have waited out or treated at home if a video consult had not been one tap away.

None of that makes the extra visits worthless — catching a treatable infection early instead of waiting it out has a real value of its own. It does mean the cost argument for telemedicine is more complicated than “it replaces an expensive visit with a cheap one,” because a meaningful share of the time, there was no expensive visit being replaced in the first place.

A second limit has nothing to do with what a video call can or can't examine, and everything to do with law: a doctor generally has to be licensed in the state or country where the patient is physically sitting at the moment of the call, not where the doctor happens to be. “Any doctor, anywhere” was always the pitch. The actual product is closer to “any licensed doctor in the specific place you are currently standing.”

That constraint is why most telemedicine platforms only work within a single country, and often only within specific states inside it, despite nothing about the technology itself caring where either person is. Multi-state licensure compacts have expanded coverage in places, but they have not erased the underlying rule, and prescribing certain controlled medications over video adds its own extra layer of requirements on top of the licence itself.

Blurring that line is where telemedicine loses people's trust, not the technology itself. A patient routed to a video call for something that needed a physical exam, and told everything is fine over the phone, has a bad experience — and the natural conclusion they draw is not “that specific visit was mis-routed,” it is “telemedicine doesn't work.”